© Reuters.
In a recent development, genetics company 23andMe announced on Tuesday that unauthorized third-party access was detected in user-created profile data shared via the DNA Relatives feature. Despite this, the company’s stock (NASDAQ:ME) remained unaffected, showing an increase of 13.92%.
According to a regulatory filing, the cyberattack occurred due to customers reusing usernames and passwords from other compromised websites. The company emphasized that the breach did not stem from an internal security flaw or misuse of company-supplied credentials.
In response to the incident, 23andMe has engaged forensic experts to investigate the extent of the attack. They are also actively working on measures to mitigate any potential damage. While the financial implications of this incident are yet to be quantified, it is clear that the company is taking proactive steps to address the issue and ensure customer data security.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
